Dose-response Relationship for Risk of Non-vertebral Fracture with Inhaled Corticosteroids

Overview

Journal Clin Exp Allergy

Specialty Allergy & Immunology

Date 2008 Jun 10

PMID 18537983

Citations 26

Authors

M Weatherall

K JAMES

J Clay

K Perrin

M Masoli

M Wijesinghe

R Beasley

Affiliations

Soon will be listed here.

Abstract

Objective: To determine the strength of association between the dose of inhaled corticosteroids (ICS) and risk of non-vertebral fracture in adults.

Methods: A systematic review and meta-analysis of case-control studies of non-vertebral fractures in adults, in which at least two doses of ICS were reported as the dose of beclomethasone dipropionate (BDP) or equivalent.

Results: Five case-control studies were identified, with a total of 43 783 cases and 259 936 controls. There was an association between the risk of non-vertebral fracture and increasing dose of BDP. The random-effects odds ratio of relative risk for a non-vertebral fracture was 1.12 (95% confidence interval 1.00-1.26) per 1000 microg increase in the daily dose of BDP or equivalent.

Conclusion: In older adults, the relative risk of non-vertebral fractures increases by about 12% for each 1000 microg/day increase in the dose of BDP or equivalent. The magnitude of this risk was considerably less than other common risk factors for fracture in the older adult.

Citing Articles

Elevated Fracture Risks in Patients Using Inhaled Corticosteroids: A Korean Nationwide Study.

Kong S, Jo A, Park C, Park K, Yun J, Kim J Endocrinol Metab (Seoul). 2024; 40(1):82-92.

PMID: 39212038 PMC: 11898311. DOI: 10.3803/EnM.2024.1990.

Pharmacokinetics of vitamin dosage forms: A complete overview.

Sugandhi V, Pangeni R, Vora L, Poudel S, Nangare S, Jagwani S Food Sci Nutr. 2024; 12(1):48-83.

PMID: 38268871 PMC: 10804103. DOI: 10.1002/fsn3.3787.

Risk of Fracture and Osteoporosis in Patients With COPD and Inhaled Corticosteroids Treatment.

Zhang N, Fan X, Zhang Y, Xu N, Li L Respir Care. 2023; 68(12):1719-1727.

PMID: 37553218 PMC: 10676258. DOI: 10.4187/respcare.10933.

Osteosarcopenia in Patients with Chronic Obstructive Pulmonary Diseases: Which Pathophysiologic Implications for Rehabilitation?.

Lippi L, Folli A, Curci C, DAbrosca F, Moalli S, Mezian K Int J Environ Res Public Health. 2022; 19(21).

PMID: 36361194 PMC: 9657186. DOI: 10.3390/ijerph192114314.

A Literature Review of the Potential Impact of Medication on Vitamin D Status.

Wakeman M Risk Manag Healthc Policy. 2021; 14:3357-3381.

PMID: 34421316 PMC: 8373308. DOI: 10.2147/RMHP.S316897.